VENUS MEDTECH HANGZHOU INC.'s next confirmed earnings release is scheduled for April 1, 2027.
| Earnings Date | 4/1/2027 |
As of June 30, 2026, VENUS MEDTECH HANGZHOU INC. has 437.90M shares outstanding.
| Shares Outstanding | 437.90M |
As of June 30, 2026, VENUS MEDTECH HANGZHOU INC. maintains a current ratio of 1.30, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.30 |
| Quick Ratio | 0.20 |
| Debt / Equity | 13.28 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 560.00 |
As of the close on October 23, 2026, VENUS MEDTECH HANGZHOU INC.'s stock has declined approximately 57.46% over the past 52 weeks.
| 52-Week Price Change | -57.46% |
As of June 30, 2026, VENUS MEDTECH HANGZHOU INC. holds 10.51M in cash and equivalents against 29.87M in total debt, resulting in a net debt position of 13.51M. Total book value stands at 224.93M, with working capital of 15.86M providing operational flexibility.
| Cash & Cash Equivalents | 10.51M |
| Total Debt | 29.87M |
| Net Debt | 13.51M |
| Equity (Book Value) | 224.93M |
| Book Value Per Share | 0.51 |
| Working Capital | 15.86M |
Already premium?